Fig. 4From: Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysisa Forest plot of the effect of intermediate-to-therapeutic versus prophylactic anticoagulation on thrombotic events in general COVID-19 patients; b Forest plot of the effect of intermediate-to-therapeutic versus prophylactic anticoagulation on thrombotic events in COVID-19 patients admitted to ICUBack to article page